Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placental Membrane Dressing for Diabetic Foot Ulcers
NCT07326553Phase 4Recruiting
- Sponsor
- BioXtek
- Start
- Dec 2025
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in diabetic foot ulcer (DFU) (2 arms), sponsored by BioXtek. Primary endpoint: Wound Closure at 12 weeks. Started Dec 2025; status: recruiting.
02
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT07326553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07326553.